FDA Submits New Cannabis Products Enforcement Policy For White House Review

FDA Submits New Cannabis Products Enforcement Policy For White House Review

The Food and Drug Administration (FDA) has submitted a proposed cannabis products enforcement policy to the White House for review that concerns regulatory issues specifically related to CBD. The White House Office of Management and Budget’s (OMB) Office of Information and Regulatory Affairs (OIRA) posted a notice that it received the submission from FDA, which falls under the U.S. Department of Health and Human Services (HHS), on Friday. While …

FDA Sends CBD Compliance and Enforcement Policy for White House Review

The Marijuana Herald - Marijuana news and information The U.S. Food and Drug Administration has submitted a notice titled Cannabidiol (CBD) Products Compliance and Enforcement Policy for review by the White House Office of Information and Regulatory Affairs on March 13. The filing is listed on Reginfo.gov as a pending EO 12866 regulatory review, with the action classified as a notice rather than a formal rule. Although the filing does not inclu…